# Radiotherapy for Prostate Cancer: Conventional Dose Versus High Dose

> **NCT00692107** · PHASE3 · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 669 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **RADIATION:** Gray
- **RADIATION:** Gray

## Key facts

- **NCT ID:** NCT00692107
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-06
- **Primary completion:** 2005-05
- **Final completion:** 2007-12
- **Target enrollment:** 669 (ACTUAL)
- **Last updated:** 2008-06-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692107, "Radiotherapy for Prostate Cancer: Conventional Dose Versus High Dose". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00692107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*